Studies of Elevated Parathyroid Activity

NCT00001277 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1553

Enrollment

NIH

Sponsor class

Conditions

Hyperparathyroidism
Hypercalcemia
Parathyroid Neoplasm
Multiple Endocrine Neoplasia
MEN1

Interventions

DRUG: 68Ga-Dotatate
DRUG: 18F-DOPA

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)